BIOMAT Database Logo BIOMAT Database Logo

Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151). 1974

R J Woodman

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011407 Propane A three carbon alkane with the formula H3CCH2CH3.
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

R J Woodman
Radiotherapy combined with ICRF 159 (NSC 129943).
January 1978, International journal of radiation oncology, biology, physics,
R J Woodman
Blood clearance of ICRF 159 (NSC-129943).
December 1971, Cancer chemotherapy reports,
R J Woodman
Effect of razoxane (ICRF 159) on daunomycin (NSC 82151) metabolism and DNA complexation.
January 1980, Drug and chemical toxicology,
R J Woodman
Treatment of Kaposi's sarcoma with ICRF-159 (NSC-129943).
January 1976, Cancer treatment reports,
R J Woodman
Treatment of the lymphomata with ICRF 159 (NSC 129943) adjunctive to combination chemotherapy.
October 1977, Irish medical journal,
R J Woodman
Effectiveness of daunomycin (NSC-82151) against experimental tumors.
December 1966, Cancer chemotherapy reports,
R J Woodman
Clinical trials of cis-diamminedichloroplatinum (NSC-119875).
April 1973, Cancer chemotherapy reports,
R J Woodman
Further experience with rezoxane (ICRF 159; -- NSC --129943) in treating Kaposi's sarcoma.
January 1980, Oncology,
R J Woodman
Preclinical toxicology studies with ICRF-159 (NSC-129943)--a new antineoplastic drug.
September 1974, Cancer chemotherapy reports. Part 3,
R J Woodman
Phase I study of ICRF-159 (NSC-129943) in human solid tumors.
April 1973, Cancer chemotherapy reports,
Copied contents to your clipboard!